168 related articles for article (PubMed ID: 31080107)
1. Moving the HIV vaccine field forward: concepts of protective immunity.
Kent SJ; Davenport MP
Lancet HIV; 2019 Jun; 6(6):e406-e410. PubMed ID: 31080107
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
[TBL] [Abstract][Full Text] [Related]
3. Role of humoral immunity in host defense against HIV.
Baum LL
Curr HIV/AIDS Rep; 2010 Feb; 7(1):11-8. PubMed ID: 20425053
[TBL] [Abstract][Full Text] [Related]
4. Immune Correlate-Guided HIV Vaccine Design.
Alter G; Barouch D
Cell Host Microbe; 2018 Jul; 24(1):25-33. PubMed ID: 30001521
[TBL] [Abstract][Full Text] [Related]
5. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
[TBL] [Abstract][Full Text] [Related]
6. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
Subbaraman H; Schanz M; Trkola A
Retrovirology; 2018 Jul; 15(1):52. PubMed ID: 30055627
[TBL] [Abstract][Full Text] [Related]
7. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.
Petitdemange C; Kasturi SP; Kozlowski PA; Nabi R; Quarnstrom CF; Reddy PBJ; Derdeyn CA; Spicer LM; Patel P; Legere T; Kovalenkov YO; Labranche CC; Villinger F; Tomai M; Vasilakos J; Haynes B; Kang CY; Gibbs JS; Yewdell JW; Barouch D; Wrammert J; Montefiori D; Hunter E; Amara RR; Masopust D; Pulendran B
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830870
[TBL] [Abstract][Full Text] [Related]
8. Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?
van Gils MJ; Schuitemaker H
Curr HIV Res; 2010 Dec; 8(8):579-86. PubMed ID: 21054254
[TBL] [Abstract][Full Text] [Related]
9. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.
Martinez DR; Permar SR; Fouda GG
Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117
[TBL] [Abstract][Full Text] [Related]
10. Complex immune correlates of protection in HIV-1 vaccine efficacy trials.
Tomaras GD; Plotkin SA
Immunol Rev; 2017 Jan; 275(1):245-261. PubMed ID: 28133811
[TBL] [Abstract][Full Text] [Related]
11. Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity.
Asefa B; Korokhov N; Lemiale F
Vaccine; 2010 Apr; 28(20):3617-24. PubMed ID: 20051277
[TBL] [Abstract][Full Text] [Related]
12. Progress in HIV-1 vaccine development.
Haynes BF; Moody MA; Alam M; Bonsignori M; Verkoczy L; Ferrari G; Gao F; Tomaras GD; Liao HX; Kelsoe G
J Allergy Clin Immunol; 2014 Jul; 134(1):3-10; quiz 11. PubMed ID: 25117798
[TBL] [Abstract][Full Text] [Related]
13. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
Sadanand S; Suscovich TJ; Alter G
Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
[TBL] [Abstract][Full Text] [Related]
14. Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1.
Pittala S; Morrison KS; Ackerman ME
Curr Opin HIV AIDS; 2019 Jul; 14(4):253-264. PubMed ID: 31033729
[TBL] [Abstract][Full Text] [Related]
15. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
16. Cure of HIV infection: is the long wait over?
Shearer WT
J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
[No Abstract] [Full Text] [Related]
17. HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity.
Wren L; Kent SJ
Hum Vaccin; 2011 Apr; 7(4):466-73. PubMed ID: 21389779
[TBL] [Abstract][Full Text] [Related]
18. An effective HIV vaccine: A combination of humoral and cellular immunity?
Benmira S; Bhattacharya V; Schmid ML
Curr HIV Res; 2010 Sep; 8(6):441-9. PubMed ID: 20636279
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
Chea LS; Amara RR
Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
[TBL] [Abstract][Full Text] [Related]
20. PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey.
Fauci AS; Marston HD
Science; 2015 Jul; 349(6246):386-7. PubMed ID: 26206922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
